2Perkins GL, Slater ED, Sanders GK, et al. Serum tumor markers [ J]. Am Faro Physician, 2003, 68(6): 1075-1082.
3Sun Z, Fu X, Zhang L, et al. A protein chip system for parallel analysis of muti-tumor markers and its application in cancer detection [ J]. Anticancer Res, 2004, 24 (2C) : 1159-1165.
4Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastriv cancer patients: a prospective clinical study [ J ]. Gastric cancer, 2003, 6 ( 3 ) : 142-145.
6Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B : a 5-year open-label follow-up study [ J ]. Lancet, 2013, 381 (9865) :468 - 75.
7Rockey D C, Bisse11 D M. Noninvasive measures of liver fibrosis [ J]. Hepatology,2006,43 (2 Suppl 1 ) : S113 - 20.
8Toyoda H, Kumada T, Kamiyama N, et al. B-mode ultrasound with algorithm based on statistical analysis of signals : evaluation of liver fibrosis in patients with chronic hepatitis C [ J ]. A JR Am J Roentgeno1,2009,193 (4) : 1037 - 43.
9曾祥婧.肝硬化文献及其5年住院患者回顾性研究.广州中医药大学,2011.
10Gyamfi MA, Wan YJ. Pathogenesis of alcoholic liver disease:the role of nuclear receptors [ J ]. Exp Biol Med ( Maywood), 2010, 235 ( 5 ) : 547-560.
